SCHEMBL67808

SCHEMBL67808

Oc1cc(Br)c(Br)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.46
ALOX12 P18054 1/20 0.46
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SNCA P37840 3/20 0.42
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
AHR P35869 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
SRC P12931 1/20 0.38
PRKACA P17612 1/20 0.38
PRKACG P22612 1/20 0.38
PRKACB P22694 1/20 0.38
APP P05067 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29878415 1.00 ALOX15 (0.46) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL4048113 0.85 ALOX15 (0.48) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL48448 0.83 ALOX15 (0.53) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL6357305 0.82 ALOX15 (0.39) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL18068460 0.82 SRC (0.41) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL30311029 0.82 ALOX15 (0.39) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL23230056 0.77 ALOX15 (0.50) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL68996 0.77 ALOX15 (0.43) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL11683175 0.77 MAPT (0.41) ALOX15ALOX12CYP3A4TSHRTDP1
SCHEMBL1697562 0.77 ALOX15 (0.38) ALOX15ALOX12CYP3A4TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262615-A1 ANTIOXIDANTS CONTAINING DIAZIRINE FUNCTIONALITIES, COMPOSITIONS COMPRISING THEM AND USE THEREOF BELLARE ANUJ (US) 2025-12-26 WO claimed
US-12194196-B2 Pro-healing elastic angiogenic microporous vascular graft UNIVERSITY OF WASHINGTON (US) 2025-01-14 US claimed
US-20240418701-A1 SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE NANJING UNIVERSITY (CN) 2024-12-19 US claimed
CN-118169963-A Fluorine-free positive photosensitive polyimide resin composition 万华化学集团股份有限公司 2024-06-11 CN claimed
CN-118103711-A Single molecule identification with reactive heterogeneous nanopores 南京大学 2024-05-28 CN claimed
CN-117402494-A Complex high-strength polyarylene sulfide based composite material and preparation and application thereof 新凝合科技(成都)有限公司 2024-01-16 CN claimed
CN-111995761-B Tripyridyl transition metal organic polymer, preparation method thereof and application thereof in carbon dioxide photocatalytic reduction 中南大学 2021-04-09 CN claimed
CN-111995761-A Tripyridyl transition metal organic polymer, preparation method thereof and application thereof in carbon dioxide photocatalytic reduction 中南大学 2020-11-27 CN claimed
US-20200261207-A1 PRO-HEALING ELASTIC ANGIOGENIC MICROPOROUS VASCULAR GRAFT UNIVERSITY OF WASHINGTON (US) 2020-08-20 US claimed
US-10667897-B2 Pro-healing elastic angiogenic microporous vascular graft UNIVERSITY OF WASHINGTON (US) 2020-06-02 US claimed
CN-111171085-A Rhamnose donor protected by orthocarbonate, and preparation method and application thereof 山东大学 2020-05-19 CN claimed
US-20180206971-A1 PRO-HEALING ELASTIC ANGIOGENIC MICROPOROUS VASCULAR GRAFT UNIVERSITY OF WASHINGTON (US) 2018-07-26 US claimed
WO-2018132445-A1 SYNTHESIS OF PHENYLETHYNYLBENZENES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2018-07-19 WO claimed
US-9981887-B1 Synthesis of phenylethynylbenzenes THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2018-05-29 US claimed
US-3970459-A Process for developing a direct reversal silver halide photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JA) 1976-07-20 US claimed
EP-3965738-B1 METHOD FOR PRODUCTION OF LIPOSOMES UNIV DO MINHO (PT) 2025-08-06 EP disclosed
US-20250195477-A1 DEUTERATED IDAZOXAN AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC. 2025-06-19 US disclosed
US-4283478-A COMPRISING A SILVER HALIDE LAYER AND A LAYER OF POSITIVE WORKING LIGHT SENSITIVE RESIN FUJI PHOTO FILM CO., LTD. (JP) 1981-08-11 US disclosed
US-3970459-A Process for developing a direct reversal silver halide photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JA) 1976-07-20 US disclosed
US-3930859-A PHOTOGRAPHIC PROCESS, SYSTEM, RECORDING MEDIUM AND MONOWEB BELL & HOWELL COMPANY (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250195477-A1 DEUTERATED IDAZOXAN AND METHODS OF USE THEREOF XDH, INA, SLC6A3 ALOX15 1328/4885ALOX12 1455/4885CYP3A4 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.